Catalyst Pharmaceuticals Inc. (NASDAQ:CPRX) announced a settlement agreement with Teva Pharmaceuticals Industries Ltd (NYSE:TEVA) to resolve patent litigation related to Firdapse (amifampridine) 10 mg ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback